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A B S T R A C T
The potential phytochemical losses occurring throughout the sequential steps of in-vitro gastrointestinal diges-
tion and colonic fermentation of a rosemary aqueous extract were investigated. Crude (CE), digested (DE) and
fermented (FE) extracts were characterized in terms of their phenolic profile and biological activities.
Rosmarinic acid was the phytochemical that underwent the most significate transformation during digestion and
fermentation, which amounted to 60% compared to the 26% degradation of the total phenolics. Overall, the
simulated digestion step decreased the antioxidant activity estimated by DPPH, ABTS, FRAP, ORAC and TBARS
assays. Both CE and DE did not present antiproliferative potential, however, FE exhibited a pronounced cytotoxic
activity (GI50= 116 µg/mL) against HeLa cells. CE and DE showed to be moderate inhibitors of methicillin-
resistant Staphylococcus aureus (MRSA), methicillin-susceptible S. aureus (MSSA), S. aureus, Listeria mono-
cytogenes, whilst the FE acted as a moderate inhibitor of MRSA and MSSA.
1. Introduction
Rosmarinus officinalis L. is a plant belonging to the Lamiaceae fa-
mily, original from the temperate countries of the Mediterranean region
and popularly known as rosemary (Andrade et al., 2018). Beyond its
worldwide use as a culinary delicacy due to its pleasant characteristic
aroma, this plant is also vastly employed for therapeutic purposes since
antiquity (Gonçalves et al., 2018).
Although most research on the rosemary herb has contemplated its
biologically active essential oil, in the past decade R. officinalis aqueous
extracts as well as their corresponding water-soluble isolated com-
pounds have been extensively investigated. In addition to expanding
knowledge about known medicinal properties of rosemary extracts,
which includes antiproliferative and anti-cancer (Petiwala & Johnson,
2015; Shrestha, Song, Kim, Lee, & Cho, 2016; Tai, Cheung, Wu, &
Hasman, 2012), anti-inflammatory (Gonçalves et al., 2018; Lucarini
et al., 2013), analgesic (Lucarini et al., 2013), neurodegenerative
(Rasoul, Maryam, Taghi, & Taghi, 2016), anti-infective (Andrade et al.,
2018) and antioxidant (Wollinger et al., 2016; Gonçalves et al., 2018)
effects, other biological activities have been reported. A rosemary
water-soluble extract, for instance, showed a great potential as anti-
matrix metalloproteinase-1 agent in human dermal fibroblasts and re-
constructed skin, thus figuring a promising ingredient for the preven-
tion of skin photo damage (Martin et al., 2008). Furthermore, the
synthesis of silver nanoparticles by using rosemary aqueous extracts
was successfully performed with the obtainment of synthesized parti-
cles with antibacterial potential against human pathogens (Ghaedi,
Yousefinejad, Safarpoor, Khafri & Purkait, 2015). Moreover, phenolic
diterpenes and phenolic acids (mainly carnosic acid, carnosol and ros-
marinic acid) isolated from rosemary extracts have presented, both in
vitro and in vivo, anti-obesity and anti-diabetic actions (Sedighi, Zhao,
Yerke, & Sang, 2015). Finally, yet importantly, rosemary water extracts
showed anti-hypertensive (Alu’datt, 2017) and hepatoprotective
(Ramadan, Khalil, Danial, Alnahdi, & Ayaz, 2013) potentials in vivo.
This great amount of evidence endorses the use of non-volatile ro-
semary extracts as functional ingredients and adjuvants in the
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treatment of several chronic diseases.
Currently, rosemary extracts are being applied as natural additives
in food products, improving the shelf life of perishable foods such as
ghee (Rahila et al., 2018) and increasing the stability of vegetable oils
(Wang et al., 2018). Based on these and similar observations the Eur-
opean Union has approved the R. officinalis extract as a secure and ef-
ficient natural food preservative, rosmarinic acid being one of its main
constituents (EFSA, 2008). Rosmarinic acid-rich extracts not only offer
proven health benefits such as anti-inflammatory, antioxidant and he-
patoprotective effects (Hasanein & Seifi, 2017; Lin et al., 2017; Villalva
et al., 2018), but also inhibit oxidation in food systems without com-
promising their sensorial acceptance, what endorses the use of those
preparations as functional food ingredients (Bakota, Winkler‐Moser,
Berhow, Eller, & Vaughn, 2015). In spite of all these studies revealing
the multiple health benefits of rosemary, scientific evidence regarding
the stability and bioavailability of their constituent bioactive com-
pounds remains very scarce (del Pilar Sánchez-Camargo & Herrero,
2017).
The aim of the present work was to investigate the potential phy-
tochemical losses occurring throughout the sequential steps of in-vitro
gastrointestinal digestion and colonic fermentation of a rosemary aqu-
eous extract, with especial interest in assessing the stability of ros-
marinic acid. For this purpose, the crude, digested and colonically
fermented rosemary extracts were comparatively characterized in terms
of their phenolic composition and also antioxidant, antibacterial and
antiproliferative potentials. A rodent model was used for colonic fer-
mentation mainly because most investigations on the biological effects
of the rosemary aqueous extract were also done in rodents. The results
should allow to correlate possible alterations in the phytochemical
profiles of the extracts with their biological activities.
2. Materials and methods
2.1. Rosemary
Dried leaves of Rosmarinus officinalis (rosemary) were purchased at
a health food store (Maringá, PR, Brazil) specialized in natural and
organic products. The producer certifies that no agrochemicals were
used in the cultivation of R. officinalis. This material constituted the
matrix used to obtain three different extracts, according to the process
shown in the diagram of Fig. 1.
2.2. Crude extract preparation
The crude extract was obtained according to the procedure pre-
viously described (Gonçalves et al., 2018), in which 20 g of grinded
rosemary leaves were suspended in 100mL of distilled water. The
suspension was stirred with the aid of a magnetic stirrer for 1 h at room
temperature (23 °C). This mixture was centrifuged at 10,000g for
10min at 4 °C and the supernatant was filtered through a qualitative
filter. The filtrate was lyophilized and stored in freezer until use.
2.3. In vitro digestion
The in vitro gastrointestinal digestion was simulated according to
methodology described previously (Correa et al., 2017). Briefly, 13 g of
the lyophilized rosemary crude extract was mixed with 39mL of arti-
ficial saliva solution (2.38 g Na2HPO4, 0.19 g KH2PO4, 8 g NaCl in 1 L of
distilled water). The pH was regulated to 6.75, at the temperature of
37 °C and α-amylase (200 U) was added. This blend was shaken at
150 rpm during 10min. In sequence, the pH was adjusted to 1.2 and
39mL of artificial gastric fluid (0.32 g pepsin in 100mL of 0.03M NaCl,
pH 1.2) was included. The mixture was then incubated on a shaker at
37 °C for 120min, under agitation of 150 rpm. Lastly, the pH was ad-
justed back to 6.0 following the addition of 6.5mL of NaCl (120mM),
6.5 mL of KCl (5 mM) and 39mL of artificial intestinal fluid (0.15 g of
pancreatin and 0.9g of bile extract in 100mL of 0.1M NaHCO3). The
mixture was incubated at 37 °C for 60min, at 150 rpm. Thereon the
obtained digested extract was freeze-dried and stored at −20 °C.
2.4. In vitro colonic fermentation
The fermentation medium, prepared as previously described by
Karppinen, Liukkonen, Aura, Forssell, and Poutanen (2000), was a
carbonate-phosphate buffer. The mineral medium was regulated to pH
7.0 and glucose was added to a final concentration of 0.8%. The mix-
ture was purged with nitrogen until the anaerobic indicator (methylene
blue) turned colorless. The inoculum was obtained from fresh feces
collected from the entire large intestines of male Wistar rats (75-days
old animals, average 250 g) immediately after euthanasia by decap-
itation under deep anesthesia (sodium thiopental 50mg/kg). Handling
of the rats was done in compliance with relevant laws and institutional
guidelines for animal experimentation and previously approved by the
Ethics Committee for Animal Experimentation of the University of
Maringá (Protocol no. 4762290915/2015-CEUA-UEM). A fecal pool of
5 animals was made. Immediately after collecting, the material was
homogenized with the culture medium at a ratio of 1:10 (w/v). The
bottles were bubbled over again with nitrogen and closed airtight.
Afterwards, the bottles were incubated at 37 °C for 24 h under agitation
of 50 rpm, in order to simulate the condition in the colonic lumen. The
initial pH was 7.0 and the final pH was around 5.0. A control with the
culture medium and inoculum was prepared. In order to verify the
absence of phenolics in the diet, the control sample was submitted to
the Folin-Ciocalteu assay, with negative results. Subsequently, the
material was ultra-centrifuged at 31,000 rpm during 30min, sterilized
by filtration (0.42 µm), and freeze-dried. As phenolic compounds and
antioxidant activity were not detected in the control, it was not con-
sidered for the antioxidant and bioactive assays.
Fig. 1. Diagram of the obtainment of the rosemary extracts, which were sub-
mitted to HPLC-DAD-ESI/MS analysis, antioxidant, cytotoxicity and anti-
bacterial assays.
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2.5. Phenolic compounds analysis
The phenolic profile was determined by LC-DAD-ESI/MSn (Dionex
Ultimate 3000 UPLC, Thermo Scientific, San Jose, CA, USA), as pre-
viously described (Bessada, Barreira, Barros, Ferreira, & Oliveira,
2016). The extracts were re-dissolved at a concentration of 10mg/mL
in a methanol:water (80:20, v/v) mixture. Detection was performed
using a DAD (280 and 370 nm as preferred wavelengths) and in a Linear
Ion Trap LTQ XL mass spectrometer (Thermo Finnigan, San Jose, CA,
USA) equipped with an ESI source, and working in negative mode. The
identification of the phenolic compounds was performed using standard
compounds, when available, and by comparing the obtained informa-
tion with available data reported in the literature. Calibration curves for
each available phenolic standard (Extrasynthèse, Genay, France) were
constructed based on the UV signal, and the quantification was per-
formed using the most suitable phenolic compound. The results were
expressed as mg per g of extract.
2.6. Antioxidant activity evaluation
Five methods were applied to assess the antioxidant activity of the
rosemary extracts: (1) reduction power of the ferric ion (FRAP); (2)
oxygen radical absorbance radical (ORAC); (3) reduction of the 2,2-
diphenyl-1-picrylhydrazyl radical (DPPH, Sigma-Aldrich, St. Louis, MO,
USA); (4) reduction of the 2,2-azino-bis (3-ethylbenzothiazoline-6-sul-
phonate) cation (ABTS, Sigma-Aldrich, St. Louis, MO, USA) and (5)
inhibition of the production of thiobarbituric acid reactive substances
(TBARS). For evaluating the antioxidant capacity of samples successive
dilutions of the stock solution were prepared. Extracts' concentrations
(mg of lyophilized extract/mL) providing 50% of antioxidant activity
were obtained from the graphs of antioxidant activity versus sample
concentrations. Trolox (6-hydroxy-2,5,7,8-tetramethylchromane-2-car-
boxylic acid, Sigma-Aldrich, St. Louis, MO, USA) was employed as a
positive control.
FRAP and ORAC assays were conducted as described in details by
Koehnlein et al. (2016). Standard curves were constructed employing
trolox (r2= 0.99), thus the results were expressed as mmol trolox
equivalents (TE)/mg lyophilized extract.
DPPH and ABTS activities were evaluated according to metho-
dology of Corrêa et al. (2015). In order to determine the percentage of
DPPH and ABTS discoloration, the following equation was applied:
[(AControl− ASample)/AControl]× 100.
Inhibition of the generation of thiobarbituric acid reactive sub-
stances (TBARS) was assessed essentially as described by Corrêa et al.
(2015), except for the substitution of the lipid source for rat brains
(instead of porcine brains). The malondialdehyde-thiobarbituric acid
(MDA-TBA) color intensity was measured at 532 nm. Results were
calculated as inhibition ratio (%) through the equation
[(AControl− ASample)/AControl]× 100 and were expressed as IC50 values.
2.7. Cytotoxic properties evaluation
The lyophilized samples were dissolved in water at 4mg/mL and
then submitted to further dilutions. Four human tumour cell lines were
tested: MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung
cancer), HeLa (cervical carcinoma) and HepG2 (hepatocellular carci-
noma). Sulforhodamine B assay (SFB, Sigma-Aldrich, St. Louis, MO,
USA) was performed as previously described (Barros et al., 2013). For
evaluation of the cytotoxicity in non-tumour cells, a cell culture (as-
signed as PLP2) was prepared from a freshly harvested porcine liver
obtained from a local slaughterhouse, according to a procedure pre-
viously described (Abreu et al., 2011). Ellipticine (Sigma-Aldrich, St.
Louis, MO, USA) was used as positive control. Results were expressed in
GI50 values (concentration that inhibited 50% of the net cell growth).
2.8. Antibacterial activity evaluation
The microorganisms used were clinical isolates divided in seven
Gram-negative bacteria (Escherichia coli, E. coli ESBL (extended spec-
trum of beta-lactamase), Klebsiella pneumoniae, K. pneumoniae ESBL,
Morganella morganii, Pseudomonas aeruginosa and Acinetobacter bau-
mannii isolated from urine and expectoration) and five Gram-positive
bacteria (MRSA-methicillin-resistant Staphylococcus aureus, MSSA-me-
thicillin-susceptible Staphylococcus aureus, Staphylococcus aureus,
Listeria monocytogenes and Enterococcus faecalis). MIC determinations
were performed by the microdilution method and the rapid p-iodoni-
trotetrazolium chloride (INT) colorimetric assay following the metho-
dology previously described (Dias et al., 2016). MIC was defined as the
lowest extract concentration that prevented this change and exhibited
inhibition of bacterial growth.
2.9. Statistical analysis
All results were expressed as mean values and standard deviations
(SD), as an outcome of the three repetitions of the samples and con-
centrations that were used in all the assays. One-way analysis of var-
iance (ANOVA) followed by Tukey’s HSD test (p= 0.05) were applied
to analyse the chemical analytical data. The antioxidant activity results
were analysed using one-way analysis of variance (ANOVA) followed
by post hoc Student–Newman–Keuls test (p < 0.05). Analyses were
carried out using IBM SPSS Statistics, version 23.0. (IBM Corp.,
Armonk, New York, USA).
3. Results and discussion
3.1. Phenolic compounds of R. officinalis preparations
The phenolic compounds profiles of the three different preparations
of R. officinalis are presented in Table 1 and the quantifications are
presented in Table 2. All three preparations showed a very similar
profile. A total of sixteen phenolic compounds were identified, such as
ten phenolic acids (caffeic and rosmarinic acid derivatives) and six
flavonoids (luteolin and quercetin derivatives). The phenolic profile of
the aqueous extract was previously described (Gonçalves et al., 2018).
As expected, rosmarinic acid was the major component found in all
samples, followed by yunnaneic acid F, luteolin-O-glucuronide and
sagerinic acid (Table 2).
Andrade et al. (2018), in their recent review on the R. officinalis
phytochemistry, concluded that the most usual compounds present in
rosemary extracts are rosmarinic acid, camphor, caffeic acid, ursolic
acid, betulinic acid, carnosic acid and carnosol but also di- and tri-
terpenes besides essential oils. Therefore, the phenolic profiles herein
reported are corroborated by literature data. Alu’datt et al. (2017),
using reversed phase HPLC, identified a distinct set of phenolic com-
pounds in a water extract of R. officialis. However, these authors also
found caffeic acid (more than 73%), rosmarinic acid (almost 7%), lu-
teolin and quercetin in different quantities.
Despite the fact that the optimal conditions for extracting rosemary
triterpenoid and phenolic acids remain uncertain, it is known that
rosmarinic acid is more soluble in aqueous solutions, normally the
process at lower temperature (< 50 °C) being recommended in order to
minimize both energy consumption and degradation of thermo-labile
substances (Bernatoniene et al., 2016). However, in a previous work of
our group, Ribeiro et al. (2016) characterized an aqueous extract of
rosemary obtained by infusion with boiling water and found ex-
pressively greater contents of rosmarinic acid (68.5mg/g), yunnaneic
acid F (10.14 mg/g), lithospermic acid (9.9 mg/g), sagerinic acid
(7mg/g), luteolin (3.6 mg/g) and caffeic acid (1.1 mg/g), than those
given in Table 2. Recently, Achour et al. (2018) characterized a hot
water extract of R. officinalis (Tunisian rosemary tea) finding almost
fifty phytochemicals, among which flavonoids, phenolic acids,
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terpenes, jasmonate, and lignans were identified. Rosmarinic acid (al-
most 160 μg/g dried rosemary) was the major extracted constituent,
whereas luteolin-7-O-rutinoside was the phytochemical with the lowest
concentration in the same extract.
In general, the most pronounced phytochemical losses occurred
throughout the simulated digestion step, after which a 26% reduction in
the total phenolic (TP) content was observed. Correa, Gonçalves et al.
(2017), when investigating the stability of yerba mate phenolic com-
pounds throughout in vitro digestion and fermentation, reported re-
ductions of 20–33% after the simulated digestion stage. Rosmarinic
acid decreased by almost 61% after digestion, while a milder reduction
for the other phenolic compounds was observed. Still, after the colonic
fermentation process, our R. officinallis extract presented an additional
TP content reduction of almost 21%, being that at this stage the ros-
marinic acid underwent a new degradation of 13.7%. Sagerinic acid
and luteolin were the compounds with the most pronounced alterations
in the fermentation step, suffering depletions around 42% and 55%,
respectively. Correa, Gonçalves et al. (2017) observed a more drastic
decrease in the TP values for yerba mate tea (33%), whereas Corrêa,
Haminiuk et al. (2017) reported minimal changes in the total
anthocyanin content of a grape pomace ethanolic extract submitted to
in vitro fermentation posteriorly to simulated digestion.
Zorić et al. (2016) performed a comparative study on the stability of
rosmarinic acid in water extracts of thyme, winter savory and lemon
balm (all Lamiaceae species, such as rosemary) and the stability of pure
rosmarinic acid after a two-phase in vitro digestion process using human
gastric and duodenal juices. HPLC-DAD analysis showed that the sta-
bility of pure rosmarinic acid was notably superior to that of rosmarinic
acid present in vegetal extracts, during both gastric and intestinal di-
gestion phases. According to the authors, the stability of rosmarinic
acid was not significantly impacted by temperature (37 °C) and slightly
alkaline medium (pH=7.5), although it presented a significant re-
duction (≥50%) when in acid medium (pH=2.5). Conclusively,
human gastrointestinal juices concentrations directly affect rosmarinic
acid stability.
Although some studies indicate that rosmarinic acid is metabolized
by the gut microbiota into caffeic acid and derivatives before its ab-
sorption, information on the microorganisms and enzymes involved in
such biotransformation is limited (Bel-Rhlid et al., 2009; Lafay & Gil-
Izquierdo, 2008). Gaps regarding absorption, metabolism and urinary
Table 1
Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data and tentative identification of the phenolic compounds
present in the crude extract, in vitro digestion preparation extract and colonic fermentation extract of Rosmarinus officinalis.
Peak Rt (min) λmax (nm) [M−H]− (m/z) MS2 (m/z) Tentative identification
1 6.8 288 341 179(100),135(2) Caffeic acid hexoside
2 8.9 318 387 369(26),207(100),163(47) Caffeic acid acetylhexoside
3 10.4 297/sh323 179 135(100) Caffeic acid
4 12.2 282/sh337 357 313(35),269(100),203(56),159(62),109(48) Prolithospermic acid
5 13.9 280 555 493(69),359(18),313(32),295(100),197(23),179(28) Lithospermic acid A isomer
6 16.2 275 597 359(18),295(18),197(63),179(58),135(98) Yunnaneic acid F
7 19.01 345 461 285(100) Luteolin-3-O-glucuronide
8 21.1 276 777 735(33),597(25),579(89),381(25),337(15),311(12),293(15),179(22),135(25) Caffeic acid derivative (tetramer)
9 22.1 283 719 539(48),521(18),359(100),297(16),179(3),161(5) Sagerinic acid isomer
10 22.7 326 655 609(53),301(100) Quercetin-acetylrutinoside
11 22.8 328 359 197(95),179(92),161(100),135(55) Rosmarinic acid
12 25.2 269/sh340 461 285(100) Luteolin-O-glucuronide
13 27.4 324 493 359(100), 313(15), 295(65), 269(6) Salvianolic acid A
14 29.15 330 503 285(100) Acetylluetolin-O-glucuronide
15 29.6 337 503 285(100) Acetylluetolin-O-glucuronide
16 31.4 337 503 285(100) Acetylluetolin-O-glucuronide
Table 2
Phenolic compounds quantification (mg/g) in the crude extract, in vitro digestion preparation extract and colonic fermentation extract of Rosmarinus officinalis
(mean ± SD).
Peak Crude extract In vitro digestion Colonic fermentation
Caffeic acid hexoside(A) 0.024 ± 0.001b 0.0304 ± 0.0001a tr
Caffeic acid acetylhexoside(A) tr tr tr
Caffeic acid(A) 0.054 ± 0.001a 0.036 ± 0.001b 0.031 ± 0.001c
Prolithospermic acid(A) 1.43 ± 0.05a 1.20 ± 0.02b 1.182 ± 0.005c
Lithospermic acid A isomer(B) 1.50 ± 0.01a 0.93 ± 0.02c 0.99 ± 0.01b
Yunnaneic acid F(B) 5.6 ± 0.2a 5.1 ± 0.2b 4.49 ± 0.11c
Luteolin-3-O-glucuronide(C) 1.6 ± 0.1a 1.39 ± 0.04b 0.99 ± 0.01c
Caffeic acid derivative (tetramer) (A) 0.117 ± 0.003a 0.059 ± 0.002b 0.059 ± 0.001b
Sagerinic acid isomer(B) 2.44 ± 0.02a 2.09 ± 0.01b 1.22 ± 0.05c
Quercetin-acetylrutinoside(D) tr tr tr
Rosmarinic acid(B) 6.9 ± 0.2a 2.7 ± 0.1b 2.33 ± 0.04c
Luteolin-O-glucuronide(C) 3.9 ± 0.1a 3.56 ± 0.02b 1.62 ± 0.02c
Salvianolic acid A(B) 1.8 ± 0.1a 1.21 ± 0.01b 1.2 ± 0.1b
Acetylluetolin-O-glucuronide(C) 1.6 ± 0.01a 1.44 ± 0.01b 1.33 ± 0.01c
Acetylluetolin-O-glucuronide(C) 1.6 ± 0.1a 1.4 ± 0.1b 1.08 ± 0.02c
Acetylluetolin-O-glucuronide(C) 1.6 ± 0.1a 1.06 ± 0.01b 1.061 ± 0.001b
Total phenolic acids 19.8 ± 0.6a 13.3 ± 0.3b 11.5 ± 0.2c
Total flavonoids 10.4 ± 0.4a 8.9 ± 0.1b 6.08 ± 0.05c
Total phenolic compounds 30 ± 1a 22.2 ± 0.4b 17.6 ± 0.1c
tr – traces; nd – not detected. Standard calibration curves: A – Caffeic acid (y=388345x+406369, R2=0.9939); B – Rosmarinic acid (y=191291x− 652903,
R2=0.999); C – luteolin-6-C-glucoside (y=4087.1x+72589, R2=0.999); D Quercetin-3-O-rutinoside (y=13343x+76751, R2=0.9998). In each row and for
the different extraction procedures, different letters mean significant differences (p < 0.05).
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excretion of rosmarinic acid in humans still need to be fulfilled, how-
ever, the available evidence suggests differences in its metabolism be-
tween humans and rats (Baba et al., 2005).
Bel-Rhlid et al. (2009) studied the in vitro hydrolysis of rosmarinic
acid using diverse esterases and the probiotic microorganism Lactoba-
cillus johnsonii. In addition, experiments with the gastrointestinal (GI)
tract model (TIM-1), which consists of four connected compartments
mimicking the stomach, duodenum, jejunum, and ileum, were also
performed. The aim was to verify if this hydrolysis happens under one
of these circumstances: (1) chemically due to the environmental con-
ditions (temperature, pH and bile salts) of the TIM-1 model; (2) cata-
lyzed by secreted enzymatic activity, or (3) catalyzed via selected en-
zymes and microorganisms. No rosmarinic acid hydrolysis was detected
under the physiological conditions of the TIM-1 model, neither was the
transformation of this compound found to be catalyzed by the secreted
lipase and pancreatic enzymes. However, the incorporation of L. john-
sonii cells into the rosemary extract in the GI model promoted a hy-
drolysis of the interest compound of almost 100%. Therefore, the re-
sults of Bel-Rhlid et al. (2009) endorse the hypothesis that rosmarinic
acid is degraded by the gut microbiota prior to absorption and meta-
bolization.
Controversially, when compared to the data obtained by Bel-Rhlid
et al. (2009), in our experiments the major rosmarinic acid degradation
was observed during the in vitro digestion step, although a significant
additional decrease occurred in the fermentation process using rat
feces. The main cause for the increased loss of rosmarinic acid in our
experiments could be the use of a pancreatic extract with a higher
content in esterases. Although this seems a plausible explanation for the
different observations, this interpretation cannot be regarded as a de-
finitive one in as much as no corresponding increments in the contents
of caffeic acid and derivatives were observed after this process. For this
equally puzzling observation the cause may also be rather simple, al-
though its confirmation depends on additional experimental activity.
One cannot exclude that caffeic acid may also have undergone trans-
formation so that the detected contents correspond actually to the net
difference between production and transformation reactions.
3.2. Evaluation of bioactive properties
The in vitro antioxidant, antibacterial and antiproliferative proper-
ties, besides hepatotoxicity, of the three rosemary preparations were
assessed and the results are compiled in Tables 3–5.
3.2.1. Antioxidant activity
Five distinct antioxidant tests were used to evaluate the antioxidant
capabilities of the rosemary preparations. The use of more than two
methods for assessing antioxidant capacity of plant extracts is im-
portant, considering that antioxidant compounds act by distinct me-
chanisms, each having its specific target within the reaction matrix
(Corrêa, Haminiuk, Sora, Bergamasco & Vieira, 2014). Thus,
heterogeneous chemical reactivities imply in different degrees of anti-
oxidant activity in the various chemical assays (Correa et al., 2017). To
our best knowledge, this is the first report on the study of the anti-
oxidant potential of an aqueous extract of R. officinalis using such a set
of techniques.
As shown in Table 3, our crude rosemary extract showed promising
values of antioxidant capacity in all trials. El-Naggar, Abdel-Farid,
Germoush, Elgebaly, and Alm-Eldeen (2016) and Kontogianni et al.
(2013) found less expressive results for, respectively, methanolic
(IC50= 55 µg/mL) and ethyl acetate (IC50= 40.6 µg/mL) extracts of
rosemary measured via DPPH assay.
The simulated digestion significantly impacted the antioxidant ac-
tivity estimated by all methods (except for ORAC), causing reductions
of 34.7%, 22.1% and 41.7% in the DPPH, ABTS and TBARS assays,
respectively, but an increase of 31.3% in the FRAP assay. Although the
colonic fermentation step did not cause significant changes detectable
by most methods, it promoted a 32.4% increase in the antioxidant ac-
tivity assessed by the ORAC method and an additional decrease in the
antioxidant capacity measured by the TBARS assay, this time of 33.3%.
Correa, Gonçalves et al. (2017), when assessing the antioxidant activity
of mate beverages using the same set of techniques, reported that the in
vitro digestion and fermentation processes caused a decrease in the
antioxidant capabilities of their samples, except for the ABTS assay.
Corrêa, Haminiuk et al. (2017), on their turn, found that the digestion
step did not cause such impacts on a grape pomace hydroalcoholic
Table 3
Antioxidant activity of Rosmarinus officinalis preparations assessed by five dis-
tinct antioxidant methods.
Antioxidant assay Crude extract In vitro digestion Colonic fermentation
DPPH EC50 (µg/mL) 14.93 ± 0.54a 20.11 ± 0.47b 19.99 ± 0.15b
ABTS EC50 (µg/mL) 6.46 ± 0.31a 7.89 ± 0.32b 8.02 ± 0.40b
FRAP (mM TE/mg
material)
2.46 ± 0.25a 1.69 ± 0.14b 1.76 ± 0.22b
ORAC (mM TE/mg
material)
9.06 ± 0.53a 8.19 ± 0.61a 5.54 ± 0.04b
TBARS EC50 (µg/mL) 260.36 ± 6.72a 369.41 ± 27.26b 554.02 ± 16.42c
The results are presented as mean ± SD. In each line different letters mean
significant statistical differences (p < 0.05). EC50 values correspond to the
sample concentration providing 50% of antioxidant activity.
Table 4
Cytotoxic properties (µg/mL) of the crude extract, in vitro digestion preparation









Antiproliferative activity (GI50 µg/mL values)
MCF-7 (breast
carcinoma)
> 400 >400 >400 0.91 ± 0.04
NCI-H460 (lung
cancer)
> 400 >400 >400 1.03 ± 0.09
HeLa (cervical
carcinoma)
> 400 >400 116 ± 10 1.91 ± 0.06
HepG2 (hepatocellular
carcinoma)
> 400 >400 >400 1.14 ± 0.21
Hepatotoxicity (GI50 µg/mL values)
PLP2 >400 >400 >400 3.22 ± 0.67
Table 5
Antimicrobial activity (MIC values, mg/mL) of the crude extract, in vitro di-








Acinetobacter baumannii 2.5 5 20
Escherichia coli ESBL 5 5 5
Escherichia coli 5 5 5
Klebsiella pneumoniae 20 20 20
Klebsiella pneumoniae ESBL 10 10 10
Morganella morganii 2.5 2.5 2.5
Pseudomonas aeruginosa 20 20 >20
Gram positive bacteria
Enterococcus faecalis 5 10 10
Listeria monocytogenes 1.25 0.625 5
MRSA 0.625 1.25 1.25
MSSA 0.625 1.25 1.25
Staphylococcus aureus 1.25 1.25 2.5
MIC values correspond to the minimal sample concentration that inhibited the
bacterial growth.
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extract, although the fermentation step caused quite significant reduc-
tions in the antioxidant capacity evaluated by the DPPH scavenging
activity and TBARS inhibition.
In order to prevent the degradation of the bioactive components of
rosemary extracts (mainly rosmarinic acid) and therefore to ensure
their functionality as food ingredients, the use of microencapsulation
techniques constitute a very interesting and effective strategy. Ribeiro
et al. (2016), in a previous study of our group, showed the feasibility of
applying rosemary aqueous extracts to functionalize cottage cheeses.
With the aim at preserving extracts’ antioxidant activity, the authors
microencapsulated a lyophilized rosemary aqueous extract by using an
atomization/coagulation technique and calcium alginate as coating
material. The process, which had an encapsulation efficiency of almost
100%, did not interfere with the nutritional value of the products. Most
important, cheese samples incorporated with microencapsulated ex-
tracts presented superior antioxidant properties throughout their shelf
life when compared with the control.
3.2.2. Cytotoxic properties
Data regarding the antiproliferative effects of the R. officinalis ex-
tracts on four human tumor cell lines (MCF-7, NCI-H460, HeLa and
HepG2) are displayed in Table 4, expressed as concentrations pro-
moting 50% of cell growth inhibition (GI50). Both the crude and di-
gested rosemary extracts did not present antiproliferative effects
against any of the tested tumor cell lines. Interestingly, the fermented
rosemary extract exhibited a considerable cytotoxic activity
(GI50= 116 µg/mL) against one of the cancer cell lines, namely the
HeLa (cervical carcinoma). Corrêa, Haminiuk et al. (2017), when ana-
lysing grape pomace preparations, reported a similar trend: the crude
and digested extracts presented no antiproliferative effects against the
same cell lines herein assessed. The corresponding grape pomace fer-
mented extract displayed antiproliferative activity against all tumor
cells, with a GI50 value of 251 µg/mL against HeLa cells. Likewise,
Correa, Gonçalves et al. (2017) found that the colonic fermentation
process improved the cytotoxicity of a mate tea extract against MCF-7,
NCI-H460 and HeLa cell lines.
In the past years, three diterpenes isolated from rosemary extracts,
namely carnosic acid, carnosol and rosmanol, have received great at-
tention of the scientific community due to their promising anti-cancer
effects, verified both in in vitro and in vivo studies (Petiwala & Johnson,
2015). Đilas et al. (2012), which assessed the antiproliferative effects of
three R. officinalis commercial oil-soluble formulations (with carnosic
acid as their main active component), found average IC50 values of
10.59 µg/mL and 12.37 µg/mL against HeLa and MCF-7 tumor cell
lines, respectively. Tai et al. (2012) showed that a R. officinalis hydro-
ethanolic extract inhibited the proliferation of ovarian cancer cell lines
and synergistically improved the effects of the chemotherapeutic cis-
platin, activity attributed to extract’s phenolic components with mole-
cular weight inferior to 1000 Da. In addition, sageone, an abietane-type
phenolic diterpene isolated from a rosemary aqueous methanol extract,
displayed a significant cytotoxic action against SNU-1 human gastric
cancer cells (Shrestha et al., 2016). More recently, Amar et al. (2017)
reported that a R. officinalis ethyl acetate fraction (rich in phenolic di-
terpenes carnosol, carnosic acid and methyl carnosate) exerted pro-
nounced antiproliferative action against U937 and CaCo-2 cells, with
IC50 values of 14.8 μg/mL and 14.95 μg/mL, respectively.
Considering that the rosemary components herein identified un-
derwent significant reductions throughout the digestion and fermen-
tation steps (Table 2), the phytochemicals involved in our rosemary
extract’s antiproliferative activity against HeLa tumor cells are probably
not those shown in Table 1. Thus, other components of our rosemary
aqueous preparation, including non-phenolic compounds, may indeed
be responsible for its antiproliferative effects. Finally, we consider the
hypothesis that the fecal microbiota that transformed the extract during
the in vitro fermentation process could play a role in its bioactivity.
None of the rosemary preparations presented toxicity against the
liver primary culture PLP2, once their GI50 values were all higher than
the highest concentration tested (400 μg/mL) (Table 5). Actually, El-
Naggar et al. (2016) confirmed the effectiveness of a rosemary hydro-
methanolic extract against the cyclophosphamide-induced hepatotoxi-
city in a mice model due to its high antioxidant activity. The herein
verified absence of cytotoxicity against liver cells, on its turn in a great
in vitro model for assessing human cytotoxicity, is a crucial issue con-
sidering the potential application of the tested rosemary preparation in
food systems (Corrêa et al., 2015).
3.2.3. Antibacterial activity
R. officinalis extracts’ minimum inhibitory concentration (MIC) va-
lues for seven Gram-negative and five Gram-positive bacteria are pre-
sented in Table 5. All the three rosemary preparations were more active
against Gram-positive bacteria than against Gram-negative bacteria.
The same observation was made by Sacco et al. (2015) when studying
the antimicrobial potential of rosemary non-volatile phenolic fractions.
Neither the simulated digestion nor the fermentation stage affected the
antimicrobial activity of our rosemary extracts against the tested Gram-
negative bacteria, except for A. baumannii. Our crude extract was more
efficient against MRSA and MSSA bacteria, with a significant decrease
of 2-fold in its inhibitory activity against Gram-positive and Gram-ne-
gative bacteria after the digestion step, although no activity alterations
were observed after the fermentation process. Several authors have
demonstrated a synergic action of rosemary isolated compounds
(especially rosmarinic and carnosic acids) with antibiotics against
MRSA clinical isolates, with promising increases in antibacterial effi-
ciency (Ekambaram et al., 2016; Vázquez, Fiorilli, Guido, & Moreno
2016). Our crude extract presented activity against L. monocytogenes,
which increased by 2-fold after the in vitro digestion, and posteriorly
reduced by 8-fold after colonic fermentation (Table 5).
Sacco et al. (2015) assessed the antimicrobial effects of three ro-
semary ethanolic extracts (with distinct phenolic compositions) against
E. coli, P. aeruginosa and S. aureus strains using a broth dilution method.
According to the authors, all tested extracts were more active against E.
coli (MBC < 0.07mg/mL), while less effective against P. aeruginosa
(MBC values around 0.20mg/mL), being the extract rich in terpenoid
derivatives, such as carnosic acid, which is known to present the best
antibacterial activity. Our data revealed a similar tendency, as our MIC
values for E. coli and P. aeruginosa were of 5mg/mL and 20mg/mL,
respectively. Klančnik, Guzej, Kolar, Abramovič, and Možina (2009),
when evaluating the activity of rosemary commercial extracts against S.
aureus ATCC 25923 (clinical isolate) via microdilution tests, reported
MIC values similar to ours (0.156–5mg/mL).
Pursuant to their MIC values, natural extracts can be classified as
strong (MIC below 0.5mg/mL), moderate (MIC between 0.6 and
1.5 mg/mL) or weak (MIC above 1.6 mg/mL) inhibitors (Corrêa et al.,
2018). Thereby, our crude and digested rosemary extracts are moderate
inhibitors of L. monocytogenes, MRSA, MSSA and S. aureus, whilst our
fermented extract is a moderate inhibitor of MRSA and MSSA. How-
ever, the three rosemary preparations are classified as weak inhibitors
against all the other bacteria herein tested. Notwithstanding, it is worth
to mention that the bacteria strains employed in our antibacterial assay
are clinical isolated multiresistant strains, which present an antibiotic
profile resistance considerably superior to the ATCC bacterial strains
(Dias et al., 2016).
4. Conclusion
In view of the relevant bioactivity exhibited by the R. officinalis
aqueous extract rich in rosmarinic acid, the outcomes herein reported
indicate its potential use as a food additive, either as a preservative
and/or as a functional ingredient. However, the use of rosmarinic acid
rich preparations as functional food ingredients should take into ac-
count the stability and bioavailability of this compound, which showed
to undergo an expressive degradation throughout the in vitro
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gastrointestinal digestion and colonic fermentation processes. In order
to avoid phytochemical losses that certainly affect the functionality of
rosemary extracts, the use of microencapsulation techniques to ensure
the delivery of these bioactive compounds could be performed and
investigated in future studies. Finally, further in vivo studies (such as
dietary intervention), are required with the purpose of unravelling and
confirming the bioactivities found in the present study.
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